Skip to main content
logo
Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China flag China · Delayed Price · Currency is CNY
19.52
+0.26 (1.35%)
Jul 31, 2026, 3:00 PM CST

Aurisco Pharmaceutical Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,6851,6971,4761,2631,008803.36
Revenue Growth
9.25%15.02%16.89%25.24%25.48%11.36%
Gross Profit
963.861,000844.36698.32512.57394.72
Operating Income
482.23532.56386.4278.83208.21182.76
Net Income
393.72449.21354.79289.42210.96168.71
Earnings Per Share
0.961.100.890.710.520.42
EPS Growth
-2.84%23.60%25.35%36.54%23.81%0%

Revenue by Segment
Chart
Fiscal YearFY 2025FY 2024
Period EndingDec '25 Dec '24
Sales of active pharmaceutical ingredients and Intermediates
1,4681,141
Sale of Drug Product
184.4220.02
Trading of active pharmaceutical ingredients and intermediates
36111.39
Others
8.733.67
Total
1,6971,476

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
917.17953.91,069545.84391.74444.61
Total Debt
969.5958.97947.85116.8852.6917.97
Net Cash (Debt)
-52.32-5.07121.42428.95339.05426.64
Net Cash Growth
---71.69%26.52%-20.53%-24.37%
Net Cash Per Share
-0.13-0.010.301.050.841.06

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
484.02421.5332.41385.61166.41201.57
Capital Expenditures
-351.74-350.07-540.28-305.48-216.23-250.61
Free Cash Flow
132.2971.42-207.8780.13-49.82-49.04
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
57.21%58.92%57.22%55.31%50.85%49.13%
Operating Margin
28.62%31.37%26.18%22.09%20.65%22.75%
Pretax Margin
26.94%30.53%27.61%26.07%23.88%23.90%
Profit Margin
23.37%26.46%24.04%22.92%20.93%21.00%
FCF Margin
7.85%4.21%-14.09%6.35%-4.94%-6.11%

Dividends
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.3400.3400.2900.2200.1600.130
Dividend Per Share Growth
17.24%17.24%31.82%37.50%23.08%8.33%
Dividend Yield
1.74%1.38%1.42%0.89%0.68%0.62%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
20.2622.6524.1836.2447.5452.34
Forward PE
-20.2018.6930.4739.8244.04
P/FCF Ratio
59.53142.46-130.89--
PS Ratio
4.675.995.818.319.9510.99